Sol-Gel Technologies Shares Outstanding 2016-2018 | SLGL

Sol-Gel Technologies shares outstanding from 2016 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Sol-Gel Technologies Annual Shares Outstanding
(Millions of Shares)
2017 6
2016 6
2015 6
Sol-Gel Technologies Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 19
Q2 2018 19
Q1 2018 15
Q4 2017 0
Q3 2017 0
Q2 2017 6
Q4 2016 0
Q4 2015 0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.110B $0.000B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $54.040B 9.28
Teva Pharmaceutical Industries (TEVA) Israel $19.138B 5.86
Mylan (MYL) United Kingdom $15.258B 6.28
Bausch Health Cos (BHC) Canada $8.076B 5.85
Dr Reddy's Laboratories (RDY) India $6.150B 24.53
Supernus Pharmaceuticals (SUPN) United States $1.988B 18.84
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.719B 2.87
Amphastar Pharmaceuticals (AMPH) United States $1.011B 109.70
Homology Medicines (FIXX) United States $0.857B 0.00
Assembly Biosciences (ASMB) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.531B 0.00
Akorn (AKRX) United States $0.451B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.415B 0.00
Voyager Therapeutics (VYGR) United States $0.269B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.247B 0.00
Teligent (TLGT) United States $0.094B 0.00
Acasti Pharma (ACST) Canada $0.087B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.069B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.056B 0.00
Evoke Pharma (EVOK) United States $0.049B 0.00
Agile Therapeutics (AGRX) United States $0.031B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.006B 0.00